Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 21, 2008; 14(23): 3681-3692
Published online Jun 21, 2008. doi: 10.3748/wjg.14.3681
Published online Jun 21, 2008. doi: 10.3748/wjg.14.3681
Figure 3 Cell cycle analysis.
A: Treatment of cell line HPAF-2 with 0.1 or 0.2 &mgr;mol/L NVP-LAQ824 for 72 h (n = 3); B: Treatment of cell line HPAF-2 with 0.1 or 0.2 &mgr;mol/L NVP-LBH589 for 72 h (n = 3); C: Treatment of cell line L3.6pl with 0.1 or 0.2 &mgr;mol/L NVP-LAQ824 for 72 h (n = 3); D: Treatment of cell line L3.6pl with 0.1 or 0.2 &mgr;mol/L NVP-LBH589 for 72 h (n = 3).
- Citation: Haefner M, Bluethner T, Niederhagen M, Moebius C, Wittekind C, Mossner J, Caca K, Wiedmann M. Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors. World J Gastroenterol 2008; 14(23): 3681-3692
- URL: https://www.wjgnet.com/1007-9327/full/v14/i23/3681.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3681